Therapeutic Potential of Nanoparticle-loaded Hydroxyurea on Proliferation of Human Breast Adenocarcinoma Cell Line

Document Type : Research article


1 Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.

2 Department of Anatomical Sciences, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.

3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran.

4 Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.


Although hydroxyurea is one of the most widely used drugs in treating breast cancer, the use of it leads to some side effects. Hence, in order to reduce complications of treatment and increase its efficiency, drug delivery has been attracted more attention. Present study included three stages. The first stage was involved in the synthesis of nanoparticles-loaded hydroxyurea that its characteristics were evaluated by using scanning electron microscopy and Zetasizer system. In the second stage, cultured MCF-7 cells were undergone treatments by hydroxyurea and Nanoparticles-loaded  hydroxyurea in various concentrations. In the third stage, the MCF-7 was treated by IC50 of hydroxyurea and nanoparticles-loaded hydroxyurea which are in combination with radiation and hyperthermia. Afterward, the viable of cell, apoptosis, and levels of caspase-8 and-9 proteins were assessed. The average size and the potential surface of nanoparticles and nanoparticles-loaded hydroxyurea were 26 nm, 48 nm, 3.86 mV, and -29.3 mV, respectively. Results of MTT assay and apoptosis represented that the percentage of cytotoxicity in the treated groups by in combination group and nanoparticles-loaded hydroxyurea was significantly increased in comparison with hydroxyurea. This increase was dependent on the concentration of nanoparticles-loaded hydroxyurea. Nevertheless, the activity of caspase-8 shows any significant changes, the activity of caspase-9 was significantly increased in the control and treatment groups. We concluded that nanoparticles-loaded hydroxyurea and it in combination with radiation and hyperthermia have higher toxicity effect on MCF-7 cells in comparison with pure hydroxyurea and induced mitochondrial-dependent apoptosis by down-regulation of caspase-8 and up-regulation of caspase-9 expressions.

Graphical Abstract

Therapeutic Potential of Nanoparticle-loaded Hydroxyurea on Proliferation of Human Breast Adenocarcinoma Cell Line


Main Subjects

(1) Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi
Jarrahi A, Malekezadeh R and Parkin D M. Cancer
occurrence in Iran in 2002, an international perspective. Asian Pac. J. Cancer Prev. (2005) 6: 359.
(2) Decatris M, Sundar S and O’Byrne KJ. Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat. Rev. (2004) 30:
(3) Praetorius NP and Mandal TK. Engineered nanoparticles in cancer therapy. Recent Pat. Drug Deliv. Formul. (2007) 1: 37-51.
(4) Sheng WY and Huang L. Cancer immunotherapy and
nanomedicine. Pharm. Res. (2011) 28: 200-14.
(5) Cho K, Wang X, Nie S and Shin DM. Therapeutic
nanoparticles for drug delivery in cancer. Clin. Cancer Res. (2008) 14: 1310-6.
(6) Gupta AK and Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical
applications. Biomaterials (2005) 26: 3995–4021.
(7) Thiele J, Kvasnicka HM, Schmitt Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl
V, Zankovich R and Schaefer HE. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa
on bone marrow morphologic features in chronic
myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features. 
Effect of Nanoparticle-loaded Hydroxyurea on Breast Cancer Cell Line
Am. J. Clin. Pathol. (2000) 114: 57-65.
(8) Van Vlerken LE, Vyas TK and Amiji MM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm. Res. (2007)
24: 1405–14.
(9) Yofee S, Leshuk T, Everett P and Gu F. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use
with MRI and other biomedical applications. Curr.
Pharm. Des. (2013) 19: 493-509.
(10) Jabbari N, Zarei L, Esmaeili Govarchin Galeh H and
Mansori Motlagh B. Assessment of synergistic effect of combining hyperthermia
with irradiation and calcium carbonate nanoparticles on proliferation of human breast adenocarcinoma cell line (MCF-7 cells). Artif. Cells Nanomed.
Biotechnol. (2018) 46: 364–72.
(11) Lee J, Chatterjee DK, Lee MH and Krishna S. Gold
nanoparticles in breast cancer treatment: promise
and potential pitfalls. Cancer Lett. (2014) 347:
(12) Baharara J, Ramezani T, Divsalar A, Mousavi M
and Seyedarabi A. Induction of apoptosis by green
synthesized gold nanoparticles through activation
of caspase-3 and 9 in human cervical cancer cells.
Avicenna J. Med. Biotechnol. (2016) 8: 75–83.
(13) Dewey WC. Arrhenius relationships from the
molecule and cell to the clinic. Int. J. Hyperthermia
(2009) 25: 3-20.
(14) Elengoe A and Hamdan S. Heat sensitivity between
human normal liver (WRL-68) and breast cancer
(MCF-7) cell lines. J. Biotechnol. Lett. (2013) 4:
(15) Hashemi M, Karami Tehrani F and Ghavami S.
Cytotoxicity effect of cladribine on the MCF-7
human breast cancer cell line. Iran. Biomed. J.
(2004) 8: 7-12.
(16) Esmaeili Govarchin Galeh H, Delirezh N, Abtahi
Froushani S and Afzale Ahangaran N. Calcitriol
modulates the effects of the supernatants of bonemarrow-derived mesenchymal stem cells on
neutrophil functions. Turk. J. Biol. (2014) 38: 365-70.
(17) Abtahi Froushani SM, Esmaili Gouvarchin
Galee H, Khamisabadi M and Lotfallahzade B.
Immunomudulatory effects of hydroalcoholic
extract of Hypericum perforatum. Avicenna J.
Phytomed. (2015) 5: 62–8.
(18) Abtahi Froushani SM, Esmaili Gourvarchin Galeh
H. New insight into the immunomodulatory
mechanisms of Tretinoin in NMRI mice. Iran. J.
Basic Med. Sci. (2014) 17: 632-7.
(19) Sinha R, Kim Gj, Nie S, and Shin DM.
Nanotechnology in cancer therapeutics:
bioconjugated nanoparticles for drug delivery.
Mol. Cancer Ther. (2006) 5: 1909-17.
(20) Pechar M, Ulbrich K, Subr V, Seymour LW and
Schacht EH. Poly(ethylene glycol) multiblock
copolymer as a carrier of anti-cancer drug
doxorubicin. Bioconjugate Chem. (2000) 11: 131–9.
(21) Kratz F, Warneke A, Scheuermann K, Schwab
J, Lazar P and Unger C. Probing the cysteine-34
position of endogenous serum albumin with thiolbinding doxorubicin derivatives: improved efficacy
of an acid-sensitive doxorubicin derivative with
specific albumin-binding properties compared with
that of the parent compound. J. Med. Chem. (2002)
25: 5523–33.
(22) Vasey PA, Kaye SB, Morrison R, Twelves C, Wilson P, Duncan R and Cassidy J. Phase I clinical
and pharmacokinetic study of PK1 (N-(2-hydroxypropyl) methacrylamide copolymer doxorubicin):
first member of a new class of chemotherapeutic
agents-drug-polymer conjugates. Cancer Research
Campaign Phase I/II Committee. Clin. Cancer Res.
(1999) 5: 83–94.
(23) Hoes C, Grootoonk J and Duncan R. Biological
properties of adriamycin-bound to biodegradable
polymeric carriers. J. Control. Release (1993) 23:
(24) Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. (2003) 2: 347-60.
(25) Mu K, Zhang S, Ai T, Jiang J, Yao Y, Jiang L
and Zhu W. Monoclonal antibody-conjugated
superparamagnetic iron oxide nanoparticles for
imaging of epidermal growth factor receptortargeted cells and gliomas. Mol. Imaging (2015)
14: 1-12.
(26) Brentnall M, Rodriguez Menocal L, De Guevara
RL, Cepero E and Boise LH. Caspase-9, caspase-3
and caspase-7 have distinct roles during intrinsic
apoptosis. BMC Cell Biol. (2013) 14: 32.
(27) Sharifi S, Barar J, Hejazi MS and Samadi N.
Doxorubicin changes Bax /Bcl-xL ratio, caspase-8
and 9 in breast cancer cells. Adv. Pharm. Bull.
(2015) 5: 351–9.
(28) Gurunathan S, Park JH, Han JW and Kim JH.
Comparative assessment of the apoptotic potential
of silver nanoparticles synthesized by Bacillus
tequilensis and Calocybeindica in MDA-MB-231
human breast cancer cells: targeting p53 for
anticancer therapy. Int. J. Nanomedicine (2015)
10: 4203-22.